The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein
Open accessAbstract
Emerging severe acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2) variants, especially those of concern, may have an impact on the virus's transmissibility and pathogenicity, as well as diagnostic equipment performance and vaccine effectiveness. Even though the SARS‐CoV‐2 Delta variant (B.1.617.2) emerged during India's second wave of infections, Delta variants have grown dominant internationally and are still evolving. On November 26, 2021, World Health Organization identified the variant B.1.1.529 as a variant of concern, naming it Omicron, based on evidence that Omicron contains numerous mutations that may influence its behavior. However, the mode of transmission and severity of the Omicron variant remains unknown. We used computational studies to examine the Delta and Omicron variants in this study and found that the Omicron variant had a higher affinity for human angiotensin‐converting enzyme 2 (ACE2) than the Delta variant due to a significant number of mutations in the SARS‐CoV‐2 receptor‐binding domain (RBD), indicating a higher potential for transmission. Based on docking studies, the Q493R, N501Y, S371L, S373P, S375F, Q498R, and T478K mutations contribute significantly to high binding affinity with human ACE2. In comparison to the Delta variant, both the entire spike protein and the RBD in Omicron include a high proportion of hydrophobic amino acids such as leucine and phenylalanine. These amino acids are located within the protein's core and are required for structural stability. We observed a disorder–order transition in the Omicron variant between spike protein RBD regions 468–473, and it may be significant in the influence of disordered residues/regions on spike protein stability and binding to ACE2. A future study might investigate the epidemiological and biological consequences of the Omicron variant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
UniProt: a worldwide hub of protein knowledge
The UniProt Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1049 · Cited by 7,698
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
ExPASy: the proteomics server for in-depth protein knowledge and analysis
Gasteiger, E. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg563 · Cited by 5,595
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure
Capriotti, E., Fariselli, P., & Casadio, R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki375 · Cited by 2,052
Clustal Omega, Accurate Alignment of Very Large Numbers of Sequences
Sievers, F., & Higgins, D. G. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-62703-646-7_6 · Cited by 1,247
PONDR-FIT: A meta-predictor of intrinsically disordered amino acids
Xue, B., Dunbrack, R. L., Williams, R. W., Dunker, A. K., & Uversky, V. N. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.011 · Cited by 1,223
Transmissibility and transmission of respiratory viruses
Leung, N. H. L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00535-6 · Cited by 890
HexServer: an FFT-based protein docking server powered by graphics processors
Macindoe, G., Mavridis, L., Venkatraman, V., Devignes, M.-D., & Ritchie, D. W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq311 · Cited by 668
SARS-CoV-2 Variants in Patients with Immunosuppression
Corey, L., Beyrer, C., Cohen, M. S., Michael, N. L., Bedford, T., & Rolland, M. (2021) · New England Journal of Medicine · doi:10.1056/nejmsb2104756 · Cited by 437
Xu, C., Wang, Y., Liu, C., Zhang, C., Han, W., Hong, X., Wang, Y., Hong, Q., Wang, S., Zhao, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe5575 · Cited by 402
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
Tian, F., Tong, B., Sun, L., Shi, S., Zheng, B., Wang, Z., Dong, X., & Zheng, P. (2021) · eLife · doi:10.7554/elife.69091 · Cited by 389
Structure of SARS-CoV-2 spike protein
Zhang, J., Xiao, T., Cai, Y., & Chen, B. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.010 · Cited by 234
Impact of the delta variant on vaccine efficacy and response strategies
Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., Mao, Q., Xu, M., & Liang, Z. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1976153 · Cited by 219
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Sternberg, A., & Naujokat, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118056 · Cited by 217
GOR V server for protein secondary structure prediction
Sen, T. Z., Jernigan, R. L., Garnier, J., & Kloczkowski, A. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti408 · Cited by 209
Pickett, B. E., Greer, D. S., Zhang, Y., Stewart, L., Zhou, L., Sun, G., Gu, Z., Kumar, S., Zaremba, S., Larsen, C. N., et al. (2012) · Viruses · doi:10.3390/v4113209 · Cited by 178
Self-citationAlpha Helices Are More Robust to Mutations than Beta Strands
Abrusán, G., & Marsh, J. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005242 · Cited by 155
Vaccination strategies to combat novel corona virus SARS-CoV-2
Pandey, S. C., Pande, V., Sati, D., Upreti, S., & Samant, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117956 · Cited by 125
VarSite: Disease variants and protein structure
Laskowski, R. A., Stephenson, J. D., Sillitoe, I., Orengo, C. A., & Thornton, J. M. (2019) · Protein Science · doi:10.1002/pro.3746 · Cited by 118
PredyFlexy: flexibility and local structure prediction from sequence
de Brevern, A. G., Bornot, A., Craveur, P., Etchebest, C., & Gelly, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks482 · Cited by 102
The newly emerged COVID-19 disease: a systemic review
Abebe, E. C., Dejenie, T. A., Shiferaw, M. Y., & Malik, T. (2020) · Virology Journal · doi:10.1186/s12985-020-01363-5 · Cited by 100
Dudas, G., Hong, S. L., Potter, B. I., Calvignac‐Spencer, S., Niatou-Singa, F. S., Tombolomako, T. B., Neba, T. F., Vickos, U., Ulrich, M., Leendertz, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26055-8 · Cited by 81
Kumar, S. (2020) · Preprints.org · doi:10.20944/preprints202002.0071.v1 · Cited by 38
Self-citationKumar, S. (2020) · Preprints.org · doi:10.20944/preprints202003.0440.v1 · Cited by 32
Self-citationMathavan, S., & Kumar, S. (2020) · Preprints.org · doi:10.20944/preprints202012.0710.v1 · Cited by 20
Self-citationBaj, A., Novazzi, F., Ferrante, F. D., Genoni, A. P., Tettamanzi, E., Catanoso, G., Gasperina, D. D., Dentali, F., Focosi, D., & Maggi, F. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1994356 · Cited by 18
Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
Zhang, Y., Wei, Y., Yang, S., Li, Y., Wang, J., Nie, Z., Bi, Y., Liu, W., Wang, L., & Yang, L. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100183 · Cited by 10
COVID-19 Vaccine Candidates by Identification of B and T Cell Multi-Epitopes Against SARS-COV-2Preprint
Kumar, S., Mathavan, S., Jin, W. J., Azman, N. A., Subramanaiam, D., Zainalabidin, N. A. B., Lingadaran, D., Sattar, Z. A., Lakshmi, D. M., Anbananthan, P. S., et al. (2020) · Preprints.org · doi:10.20944/preprints202008.0092.v1 · Cited by 8
Self-citationOnline Resource and Tools for the Development of Drugs Against Novel Coronavirus
Kumar, S. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_53 · Cited by 7
Self-citationProtein–Protein Interaction Network for the Identification of New Targets Against Novel Coronavirus
Kumar, S. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_62 · Cited by 5
Self-citation
Cited by
Araf, Y., Akter, F., Tang, Y., Fatemi, R., Parvez, M. S. A., Zheng, C., & Hossain, M. G. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27588 · Cited by 862
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
He, X., Hong, W., Pan, X., Lu, G., & Wei, X. (2021) · MedComm · doi:10.1002/mco2.110 · Cited by 506
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Cui, Z., Liu, P., Wang, N., Wang, L., Fan, K., Zhu, Q., Wang, K., Chen, R., Feng, R., Jia, Z., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.019 · Cited by 424
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Stein, C., Nassereldine, H., Sorensen, R. J. D., Amlag, J. O., Bisignano, C., Byrne, S., Castro, E., Coberly, K., Collins, J. K., Dalos, J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02465-5 · Cited by 412
Chatterjee, S., Bhattacharya, M., Nag, S., Dhama, K., & Chakraborty, C. (2023) · Viruses · doi:10.3390/v15010167 · Cited by 313
Metadata
- Authors
- Kumar, S., Thambiraja, T. S., Karuppanan, K., & Subramaniam, G.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2021-12-27
- Volume
- 94
- Issue
- 4
- Pages
- 1641-1649
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W4200180765
- Cited by
- 579
- References
- 33
- FWCI
- 38.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.